Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study. (13th August 2019)

• Record Type: Journal Article
• Authors: Long, G V; Flaherty, K T; Stroyakovskiy, D; Gogas, H; Levchenko, E; de Braud, F; Larkin, J; Garbe, C; Jouary, T; Hauschild, A; Chiarion-Sileni, V; Lebbe, C; Mandalá, M; Millward, M; Arance, A; Bondarenko, I; Haanen, J B A G; Hansson, J; Utikal, J; Ferraresi, V; Mohr, P; Probachai, V; Schadendorf, D; Nathan, P; Robert, C; Ribas, A; Davies, M A; Lane, S R; Legos, J J; Mookerjee, B; Grob, J -J;
• Is Part Of: Annals of oncology. Volume 30:Number 11(2019)
• Page Start: 1848
• Page End: 1848
• Publication Date: 2019-08-13
• Subjects: Oncology -- Periodicals; 616.992
• DOI: 10.1093/annonc/mdz221
• Languages: English
• ISSNs: 0923-7534